EOLS – evolus, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EOLS SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
5/7/2024
04:05 pm
eols
evolus, inc.
MISS
-1.2%
3/7/2024
04:05 pm
eols
evolus, inc.
MISS
-6.2%
11/7/2023
04:16 pm
eols
evolus, inc.
MISS
10.4%
8/2/2023
04:05 pm
eols
evolus, inc.
MISS
2.1%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS
SPY
QQQ
SPX
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
5/10
09:10 am
eols
Medium
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
5/8
03:33 pm
eols
Low
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
5/8
11:24 am
eols
Low
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
08:07 am
eols
Low
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
5/7
04:19 pm
eols
Low
Evolus Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
5/7
04:05 pm
eols
Low
Evolus Reports First Quarter 2024 Results and Provides Business Update
5/3
11:34 am
eols
Low
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59% [Yahoo! Finance]
5/1
09:23 am
eols
Medium
Board Certified Celebrity Dermatologist Dr. Ava Shamban Launches Althaea Skin [Yahoo! Finance]
5/1
04:17 am
eols
Medium
Green Thumb Industries Inc. (GTBIF) Surges 22.3%: Is This an Indication of Further Gains? [Yahoo! Finance]
5/7/2024
04:05 pm
eols
-1.2%
MISS
3/7/2024
04:05 pm
eols
-6.2%
MISS
11/7/2023
04:16 pm
eols
10.4%
MISS
8/2/2023
04:05 pm
eols
2.1%
MISS
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
5/8
03:33 pm
Reiterates
Buy
Buy
HC Wainwright
Low
0.4%
5/8
08:07 am
Reiterates
Buy
Buy
Needham & Company LLC
Low
-1.3%
5/8
06:52 am
Reiterates
Buy
Buy
Needham
Low
-1.6%
5/8
06:52 am
Reiterates
Buy
Buy
Needham
Low
-1.6%
4/10
08:05 am
Reiterates
Buy
Buy
Needham & Company LLC
Low
-2.9%
4/10
06:45 am
Reiterates
Buy
Buy
Needham
Low
-2.9%
4/10
06:45 am
Reiterates
Buy
Buy
Needham
Low
-2.9%
3/8
10:35 am
Reiterates
Buy
Buy
Stifel
Low
0.4%
3/8
07:07 am
Reiterates
Buy
Buy
Needham
Low
-0.8%
5/7
05:01 pm
eols
Low
Form 10-Q Evolus, Inc. For: Mar 31
5/7
04:14 pm
eols
Low
Form 8-K Evolus, Inc. For: May 07
4/26
04:58 pm
eols
Low
Form DEFA14A Evolus, Inc.
4/26
04:57 pm
eols
Low
Form ARS Evolus, Inc. For: Dec 31
4/26
04:57 pm
eols
Low
Form DEF 14A Evolus, Inc. For: Dec 31
4/3
04:30 pm
eols
Low
Form 8-K Evolus, Inc. For: Apr 02
3/29
07:08 pm
eols
Low
Form 4 Evolus, Inc. For: Mar 27 Filed by: MOATAZEDI DAVID
3/21
06:10 pm
eols
Low
Form 4 Evolus, Inc. For: Mar 19 Filed by: Avelar Rui
3/21
06:09 pm
eols
Low
Form 4 Evolus, Inc. For: Mar 19 Filed by: Beaver Sandra
Show more
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%